Findings from two clinical studies validated the clinical utility of the Integrated Pulmonary Index (IPI) in the post anesthesia care unit to identify respiratory adverse events, and the cost-effectiveness of capnography in gastrointestinal (GI) sedation, according to a Medtronic press release.

The data, which were presented at Anesthesiology 2015, highlight the need for clinicians to actively monitor for respiratory compromise following general anesthesia and procedural sedation with both pulse oximetry and capnography, according to Medtronic.

“The findings presented today demonstrate the clinical benefits and potential cost savings capnography can provide across a broad spectrum of patients,” said Michael Tarnoff, MD, vice president and chief medical officer, Minimally Invasive Therapies Group at Medtronic. “These studies underscore Medtronic’s commitment to reducing the growing burden of respiratory compromise across clinical settings to improve the health and care of patients.”